Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Awada, G. (Speaker), Özdemir, I. (Contributor), Schwarze, J. K. (Contributor), Emma Daeninck (Contributor), Gondry, O. (Contributor), Yanina Jansen (Contributor), Teofila Seremet (Contributor), Keyaerts, M. (Contributor), Everaert, H. (Contributor), Neyns, B. (Contributor)

Activity: Talk or presentationTalk or presentation at a conference


Poster Presentation - 21P
Period14 Dec 2018
Event titleESMO Immuno-Oncology Congress 2018
Event typeConference
LocationGeneva, Switzerland
Degree of RecognitionInternational